Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II/III Randomized, Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis
This study is currently recruiting participants.
Study NCT00706147   Information provided by Emory University
First Received: June 24, 2008   Last Updated: May 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hereditary ALS
Familial ALS
SOD1 Positive ALS
Inherited ALS
Additional conditions recognized in this trial
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Sclerosis
More general conditions related to this trial
Central Nervous System Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neuromuscular Diseases
Pathologic Processes
Spinal Cord Diseases
Interventions listed in this trial
Arimoclomol
Sponsors listed in this trial
Emory University
ALS Association
FDA Office of Orphan Products Development
Massachusetts General Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services